Cargando…

PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells

BACKGROUND: Phosphatase of regenerating liver-3 (PRL-3), a protein tyrosine phosphatase, is highly expressed in multiple human cancers and strongly implicated in tumor progression and cancer metastasis. However, the mechanisms by which PRL-3 promotes cancer cell migration, invasion, and metastasis a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hao, Al-aidaroos, Abdul Qader Omer, Wang, Haihe, Guo, Ke, Li, Jie, Zhang, Hua Fei, Zeng, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620920/ https://www.ncbi.nlm.nih.gov/pubmed/23418787 http://dx.doi.org/10.1186/1471-2407-13-80

Ejemplares similares

PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
por: Thura, Min, et al.
Publicado: (2021)

Author Correction: PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
por: Thura, Min, et al.
Publicado: (2021)

PRL-3 activates mTORC1 in Cancer Progression
por: Ye, Zu, et al.
Publicado: (2015)

Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
por: Guo, Ke, et al.
Publicado: (2012)

Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia
por: Park, Jung Eun, et al.
Publicado: (2013)

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2019)

Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2021)

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
por: Chee, Cheng E., et al.
Publicado: (2023)

Metastatic Phosphatase PRL-3 Induces Ovarian Cancer Stem Cell Sub-population through Phosphatase-Independent Deacetylation Modulations
por: Zhang, Mingming, et al.
Publicado: (2019)

PRL‐3 promotes migration and invasion and is associated with poor prognosis in salivary adenoid cystic carcinoma
por: Dong, Qian, et al.
Publicado: (2015)

c-FOS suppresses ovarian cancer progression by changing adhesion
por: Oliveira-Ferrer, L, et al.
Publicado: (2014)

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
por: Radke, I, et al.
Publicado: (2006)

Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD–negative acute myeloid leukemia
por: Qu, Shuang, et al.
Publicado: (2014)

PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin β1-ERK1/2 and-MMP2 signaling
por: Peng, Lirong, et al.
Publicado: (2009)

Expression and Clinical Role of Protein of Regenerating Liver (PRL) Phosphatases in Ovarian Carcinoma
por: Reich, Reuven, et al.
Publicado: (2011)

Role of phosphatase of regenerating liver 1 (PRL1) in spermatogenesis
por: Bai, Yunpeng, et al.
Publicado: (2016)

Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer
por: Ooki, Akira, et al.
Publicado: (2011)

Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody
por: Loh, Amos Hong Pheng, et al.
Publicado: (2023)

Analysis of molecular determinants of PRL-3
por: Pascaru, Mihaela, et al.
Publicado: (2009)

Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL
por: Alam, Zohaib, et al.
Publicado: (2015)

Src-Mediated Phosphorylation of the Tyrosine Phosphatase PRL-3 Is Required for PRL-3 Promotion of Rho Activation, Motility and Invasion
por: Fiordalisi, James J., et al.
Publicado: (2013)

Depletion of Tissue-Specific Ion Transporters Causes Differential Expression of PRL Targets in Response to Increased Levels of Endogenous PRL
por: Shu, Tingting, et al.
Publicado: (2018)

MiR-130a-3p Inhibits PRL Expression and Is Associated With Heat Stress-Induced PRL Reduction
por: Zhang, Haojie, et al.
Publicado: (2020)

PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types
por: Chia, Pei Ling, et al.
Publicado: (2023)

Generation of conditional knockout alleles for PRL-3()
por: Yan, Hong, et al.
Publicado: (2011)

c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer
por: Hao, Yingying, et al.
Publicado: (2017)

Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3
por: Rubio, Teresa, et al.
Publicado: (2016)

PRL-3 promotes telomere deprotection and chromosomal instability
por: Lian, Shenyi, et al.
Publicado: (2017)

Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity
por: Gehring, Kalle, et al.
Publicado: (2020)

Binocularity Principles of PRL Development in Patients With Macular Disease
por: Tarita-Nistor, Luminita, et al.
Publicado: (2022)

PRL-3 promotes breast cancer progression by downregulating p14(ARF)-mediated p53 expression
por: Xie, Hua, et al.
Publicado: (2018)

Novel monoclonal antibody against integrin α3 shows therapeutic potential for ovarian cancer
por: Ke, Feng‐Yi, et al.
Publicado: (2020)

Overexpression of PRL7D1 in Leydig Cells Causes Male Reproductive Dysfunction in Mice
por: Liu, Yaping, et al.
Publicado: (2016)

PRL3 enhances T cell acute lymphoblastic leukemia growth through suppressing T cell signaling pathways and apoptosis
por: Garcia, E.G., et al.
Publicado: (2020)

Energy deprivation-induced AMPK activation inhibits milk synthesis by targeting PrlR and PGC-1α
por: Wu, Zhihui, et al.
Publicado: (2022)

Production of Murine Leukemia RL♂1 Rejection Antigen Peptide pRL1a by Proteolysis of Natural Precursor pRL1b
por: Ono, Toshiro, et al.
Publicado: (1996)

Pituitary Hormones (FSH, LH, PRL, and GH) Differentially Regulate AQP5 Expression in Porcine Ovarian Follicular Cells
por: Skowronski, Mariusz T., et al.
Publicado: (2019)

PRL-3, a Metastasis Associated Tyrosine Phosphatase, Is Involved in FLT3-ITD Signaling and Implicated in Anti-AML Therapy
por: Zhou, Jianbiao, et al.
Publicado: (2011)

PRL2 serves as a negative regulator in cell adaptation to oxidative stress
por: Du, Xinyue, et al.
Publicado: (2019)

Exploring Amino Acid Auxotrophy in Bifidobacterium bifidum PRL2010
por: Ferrario, Chiara, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_471uajnd9ppust4rlhuj83ds7g